Table 1 Sample demographics

Number of individuals

106

65

26

26

Diagnosis - SCD/MCI/AD

106/0/0

11/19/35

26/0/0

0/0/26

Age^a,b

59 (51 –69)

62 (51–74)

59 (51–68)

60 (51–68)

Sex - F/M^c

65/41

41/24

6/20

17/9

Aβ42 (pg/ml)^a

1160 (562–2000)

540 (248–990)

1106 (867–1495)

636 (274–804)

Aβ40 (pg/ml) ÷ 10 ^a

1134 (542–1923)

1225 (558–2185)

-

-

Aβ42/Aβ40 × 10^a

1.01 (0.73–1.29)

0.47 (0.26–0.67)

-

-

t-tau (pg/ml)^a

214 (75–907)

538 (324–1210)

232 (88–349)

784 (413–2160)

p-tau (pg/ml)^a

32 (14–56)

82 (57–190)

38 (22–50)

94 (64–185)

NfL (pg/ml) ^a,d

670 (310–3960)

1,130 (650–6,550)

-

-

Albumin CSF/serum ratio^e

5.70 (2.50–14.40)

5.4 (2.6–11.1)

-

-

MMSE ^a,f

28.0 (16.0–30.0)

23.0 (14.0–30.0)

29 (25–30)

22 (6–28)

MoCA ^a,f

26.0 (13–30.0)

20.0 (5.0–28.0)

-

-

KOD ^a,f

56 (23–98)

44 (1–72)

-

-

RAVLT ^a,f

50 (27–69)

31 (3–64)

-

-

RCF ^a,f

18 (2–32)

9 (0–33)

-

-